Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

CORDIS reúne toda la información sobre los proyectos financiados por Horizonte 2020 , y ahora también resúmenes de los informes relacionados. Se puede descargar toda la documentación de estos proyectos en el Portal de datos abiertos de la UE .

My refinements


Download results of this page


Advanced search

Búsqueda de proyectos y resultados

Results 1 - 4 of 4
Order by: Results/page:
1
Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome
ID: 755225
Fecha de inicio: 2018-01-01, Fecha de finalización: 2022-12-31
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1) gene. CN is a life-threatening disease with no cure which constitutes a severe burden for the patients, their families, and the society...
Programme: H2020-EU.3.1.3.
Record Number: 212689
Last updated on: 2018-01-23
A global alliance for Zika virus control and prevention
ID: 734548
Fecha de inicio: 2016-10-01, Fecha de finalización: 2019-09-30
"ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in the Caribbean, Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia...
Programme: H2020-EU.3.1.3.
Record Number: 207455
Last updated on: 2017-08-23
GlucoCEST Imaging of Neoplastic Tumours
ID: 667510
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
Cancer is one of the most devastating diseases the world is currently facing, accounting for 7.6 million deaths in 2008 (WHO). Cancer is usually detected through advanced medical imaging. Early detection is very important as it increases the chances of survival and the...
Programme: H2020-EU.3.1.3.
Record Number: 199734
Last updated on: 2017-07-14
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
ID: 667751
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they...
Programme: H2020-EU.3.1.3.
Record Number: 199738
Last updated on: 2016-11-29
List retrieved on: 2018-12-14
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba